BONDMODINE

This brand name is authorized in Nigeria.

Active ingredients

The drug BONDMODINE contains one active pharmaceutical ingredient (API):

1	Brimonidine UNII 4S9CL2DY2H - BRIMONIDINE TARTRATE
	Brimonidine is an alpha2-adrenergic receptor agonist that is 1000-fold more selective for the alpha2-adrenoceptor than the alpha1-adrenoreceptor. This selectivity results in no mydriasis and the absence of vasoconstriction in microvessels associated with human retinal xenografts.
	Read more about Brimonidine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1642	Eye drops	BONDMODINE EYE DROP SOL_DROPS 2 mg/mL	BONDMODINE EYE DROP B4-1642 BONDMODINE EYE DROP BRIMONIDINE TARTRATE 2MG/ML. Eye Drops Prescription Only Medicine (POM) BOND CHEMICAL INDUSTRIES LIMITED, ASALU INDUSTRIAL ESTATE AWE. AWE OYO Nigeria DIVINE LABORATORIES PVT. LTD., BLOCK NO. 471, DABHASA, TALUKA PADRA, DIST. VADODARA- 391 440, GUJARAT, INDIA., India 1/26/2023 1/25/2028	26/01/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EA05	Brimonidine	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EA Sympathomimetics in glaucoma therapy
Discover more medicines within S01EA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1642